Addex Therapeutics Ltd (ADXN)
Addex Therapeutics Ltd at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Addex Therapeutics Ltd (ADXN) is a Biotechnology company based in CH with a market capitalization of $4.1M. Revenue declined 92.6% year-over-year and free cash flow was negative at -$2.1M. This page tracks ADXN's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
CH · 2 employees · IPO Feb 12, 2020
Valuation
Valuation & price
$6.60as of May 26, 2026· -39.7% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
—
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$4.1M
Market cap
-92.6%
Revenue growth (YoY)
100.0%
Gross margin
-$2.1M
Free cash flow (USD)
-$1.6M
Net debt
Net cash position
14.4%
Share dilution
1/4
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last reported: Jun 25, 2026 (EPS $-1.48)
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- Quarterly reportJul 8, 2026Filing
Interim Results (6-K)
- Annual reportJun 30, 2026Filing
Annual Report Filed
- Annual reportJun 25, 2026Filing
Annual Report Filed
- 6-K filingJun 5, 2026Filing
Annual General Meeting Announcement
- Annual reportMay 15, 2026Filing
20-F Filed
- Annual reportApr 30, 2026Filing
Annual Report Filed
- 6-K filingApr 29, 2026Filing
Press Release
- 6-K filingApr 23, 2026Filing
Clinical Study Update
- 6-K filingApr 21, 2026Filing
Press Release
Questions
Frequently asked questions
What is Addex Therapeutics Ltd's market cap?
Addex Therapeutics Ltd (ADXN) has a market capitalization of $4.1M.
What is ADXN's P/E ratio?
A meaningful P/E ratio is not available for ADXN — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
When did Addex Therapeutics Ltd last report earnings?
ADXN last reported earnings on June 25, 2026; the next date is not yet scheduled.
Are insiders buying ADXN stock?
SEC Form 4 filings show no open-market insider buys at Addex Therapeutics Ltd in the last 90 days (0 sells).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.